tamoxifen and tirzepatide GLP-1 Agonists Poised to Impact Breast Cancer Care | Targeted Oncology Weight-loss wonder drug Mounjaro/Zepbound shrinks

Even modest BP improvements add to cardiovascular benefit

No waiting rooms, no appointments, and with optional medication delivery through a licensed pharmacy, right to your door

In this respect, GLP-1s have an added benefit for MASH patients since they have been shown to reduce the rate of major cardiovascular events, including strokes and heart attacks

The 12 mg dose produced 28.7% weight loss at 68 weeks in the TRIUMPH-4 trial

Reactive aldehydes, including MDA and 4-HNE, are key markers and mediators of OS-induced cellular damage, whose accumulation contributes to melanocyte dysfunction and death, ultimately leading to depigmentation [85]